Press Releases
Jefferson Joins the TriNetX Network to Revolutionize Clinical Trial Design to Enhance and Accelerate the Development of New Drugs
CAMBRIDGE, May 10, 2016 – TriNetX, a leader in international clinical research networks, announced today that Thomas Jefferson University signed a membership agreement to join the TriNetX network to optimize clinical trial design and advance clinical research for...
TriNetX Executes Agreement to Revolutionize Clinical Trial Design to Enhance and Accelerate the Development of New Drugs
CAMBRIDGE, March 3, 2016 – TriNetX, a leader in international clinical research networks, announced today the signing of a collaboration agreement with Novartis to optimize clinical trial design and advance clinical research for Novartis programs. Novartis researchers...